Abstract:Targeting protein for Xenopus kinesin-like protein 2 (TPX2), a well-known mitotic protein, has been linked to carcinogenesis in several cancers. This study investigated the role of TPX2 in hepatocellular carcinoma (HCC) from various aspects using bioinformatic analyses. TPX2 expression and its prognostic value in pan-cancers were analyzed using SangerBox. TPX2 expression and its association with prognosis, immune infiltration, tumor mutations, and signaling pathways in HCC were analyzed using UALCAN, BoxKaplan-Meier Plotter, GEPIA, Human Protein Atlas, TIMER 2.0, and SangerBox. Genes co-expressed with TPX2 in HCC were analyzed using the HCCDB database, followed by functional enrichment using SangerBox. Clinical predictive models were established based on TPX2 and its co-expressed genes using the ACLBI database. TPX2 expression significantly increased in pan-cancers and was associated with survival in nearly half of the cancer types. High TPX2 expression has been linked to poor survival outcomes in patients with HCC. TPX2 expression was positively correlated with abundant infiltration of immune cells (including B cells, CD4 + /CD8 + T cells, macrophages, neutrophils, and dendritic cells), TP53 mutation, and carcinogenesis-related pathways, such as the PI3K/AKT/mTOR pathway, cellular response to hypoxia, and tumor proliferation signature. Nineteen genes were found to be co-expressed with TPX2 in HCC, and these genes showed close positive correlations and were mainly implicated in cell cycle-related functions. A prognostic model established using TPX2 and its expressed genes could stratify HCC patients into high- and low-risk groups, with a significantly shorter survival time in high-risk groups. The prognostic model performed well in predicting 1-, 3-, and 5-year survival of patients with HCC, with areas under the curve of 0.801, 0.725, and 0.711, respectively. TPX2 functions as an oncogene in HCC, and its high expression is detrimental to the survival of patients with HCC. Thus, TPX2 may be a prognostic biomarker and potential therapeutic target for HCC.

TPX2 Level Correlates with Cholangiocarcinoma Cell Proliferation, Apoptosis, and EMT.

Expression of targeting protein for xenopus kinesin-like protein 2 in cholangiocarcinoma and its clinical significance

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.

Overexpressed Targeting Protein for Xklp2 (TPX2) Serves As a Promising Prognostic Marker and Therapeutic Target for Gastric Cancer.

Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma

Investigation of the expression of TPX2 in tongue squamous cell carcinoma and its effect on Cal27 cell prolifer-ation and apoptosis

Validation of TPX2 As a Novel Prognostic Marker for Malignant Progression and Metastasis of Colon Cancer.

Tpx2 is A Novel Prognostic Marker for the Growth and Metastasis of Colon Cancer

High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer

TPX2 Knockdown Suppressed Hepatocellular Carcinoma Cell Invasion Via Inactivating AKT Signaling and Inhibiting MMP2 and MMP9 Expression.

TPX 2 in Human Clear Cell Renal Carcinoma : Expression , Function and Prognostic Significance

Overexpression of TPX2 is Associated with Progression and Prognosis of Prostate Cancer

TPX2 promotes migration and invasion of human breast cancer cells

Tpx2 Regulates Tumor Growth in Human Cervical Carcinoma Cells

The TPX2 Gene is a Promising Diagnostic and Therapeutic Target for Cervical Cancer.

Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors

Prognostic Role of Targeting Protein for Xklp2 in Solid Tumors

Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.

Overexpressions of Ck2 Beta and Xiap Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

Targeting TPX2 Suppresses Proliferation and Promotes Apoptosis Via Repression of the PI3k/AKT/P21 Signaling Pathway and Activation of P53 Pathway in Breast Cancer

Prognostic and Clinical Value of Targeting Protein for Xenopus Kinesin-Like Protein 2 in Patients with Gastrointestinal Tract Cancers